Welcome to our dedicated page for Scilex Holding Co news (Ticker: SCLX), a resource for investors and traders seeking the latest updates and insights on Scilex Holding Co stock.
Scilex Holding Company (SCLX) delivers innovative non-opioid therapies for pain management and complex chronic conditions. This dedicated news hub provides investors and healthcare professionals with timely updates on regulatory milestones, clinical developments, and strategic initiatives shaping the company's growth.
Access verified information about SCLX's FDA-approved products like ZTlido® and ELYXYB®, plus progress updates on pipeline candidates including SP-102 for sciatica. Our curated news collection covers earnings reports, partnership announcements, and scientific advancements – all essential for understanding the company's market position.
Key updates include new therapy approvals, clinical trial results, intellectual property developments, and executive leadership changes. Bookmark this page for direct access to press releases and third-party analyses, ensuring you stay informed about SCLX's contributions to non-addictive pain management solutions.
Scilex Holding Company (Nasdaq: SCLX) closed the second tranche of its strategic investment in Datavault AI (Nasdaq: DVLT) on Nov 26, 2025, completing a two‑tranche equity financing.
Scilex purchased a pre‑funded warrant exercisable for 263,914,094 shares of Datavault common stock, paid in Bitcoin based on the spot rate at signing, and has exercised the warrant in full.
The shares issued upon exercise have an approximate value of $583.3 million based on Datavault's closing price of $2.21 on Nov 25, 2025. Datavault stockholder approval was obtained at the Nov 24, 2025 annual meeting. Both companies plan to ramp collaboration on Real World Asset tokenization in 2026.
Scilex Holding Company (Nasdaq: SCLX) announced the closing of reduced-price exercises of existing warrants, generating approximately $20.3 million gross proceeds on Nov 25, 2025. The exercises converted 904,396 shares of common stock at a reduced $22.51 per share.
In exchange, the company issued a new unregistered warrant to purchase up to 1,356,594 shares at a $29.00 exercise price, exercisable immediately for five years. Net proceeds are expected to be used for working capital and general corporate purposes.
Scilex Holding Company (Nasdaq: SCLX) announced a definitive agreement for the cash exercise of existing warrants to purchase an aggregate of 904,396 shares of common stock, generating approximately $20.3 million in gross proceeds before placement agent fees and offering expenses.
In exchange for immediate cash exercise, the company will issue a new unregistered warrant to purchase up to 1,356,594 shares at an exercise price of $29.00 per share, exercisable immediately with a five-year term. The offering is expected to close on or about November 25, 2025, and net proceeds are planned for working capital and general corporate purposes.
Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) intends to voluntarily distribute Dream Bowl 2026 Meme Coins to Scilex record holders as of November 25, 2025, concurrent with Datavault AI's own eligible holders.
Nasdaq told Datavault AI it will not make an announcement for Scilex about the distribution date. Distribution is conditional on recipients opting in, setting up a Data Vault® wallet, and providing documentation. Datavault AI's board may change the record date and will set the payment date within 60 days after the record date; payment is conditioned on the board not revoking the distribution.
Scilex Holding Company (Nasdaq: SCLX) said Datavault AI (Nasdaq: DVLT) approved a distribution of a Dream Bowl 2026 Meme Coin to eligible Scilex and Datavault AI stockholders.
Key mechanics: the record date is November 25, 2025, the ex-dividend date is November 24, 2025, and holders of record will receive one Dream Bowl 2026 Meme Coin per share. Datavault AI plans to airdrop handcrafted digital coins into Data Vault wallets and will collect shareholder wallet info; distribution begins on or after December 8, 2025. Datavault may revoke or change the distribution or record date; the Payment Date will be set within 60 days after the record date.
The Dream Bowl event is scheduled for January 11, 2026 at AT&T Stadium and will include drone racing and e-sports championships.
Scilex Holding Company (Nasdaq: SCLX) announced a worldwide exclusive license, with sublicense rights, to Datavault AI’s AI-driven technology to build a Biotech Exchange for tokenizing, trading and monetizing biotech assets including genomic, DNA, diagnostic, therapeutic and drug data.
The agreement includes a non-refundable upfront license fee payable in four equal installments of $2.5 million (totaling $10.0 million) due by September 30, 2026 and contingent sales milestone payments of up to $2.55 billion. The license covers a portfolio of issued and pending patents, including key pending U.S. application 17/941,623 for tokenizing DNA data.
Scilex Holding Company (Nasdaq: SCLX) announced it will sponsor Dream Bowl 2026 and set a record date of November 14, 2025 for shareholders to receive a Dream Bowl 2026 meme coin distributed by DataVault AI. Shareholders of record on November 14, 2025 will receive one meme coin per common share. Handcrafted digital coins will be airdropped to Data Vault wallets on or after November 25, 2025. The Dream Bowl event is scheduled for January 11, 2026 at AT&T Stadium in Dallas, with additional drone racing and e-sports championships included.
Scilex Holding Company (Nasdaq: SCLX), a non-opioid pain management company, has completed the first tranche of its warrant repurchase agreement with Oramed Pharmaceuticals. The company has repurchased 3,130,000 warrants at $0.01 exercise price for $13 million.
Under the previously disclosed option agreement, Scilex has the right to repurchase a total of 6,500,000 warrants in two tranches for a total of $27 million. The company retains the option to repurchase the remaining 3,370,000 warrants for $14 million before December 31, 2025.
Datavault AI (Nasdaq: DVLT) has completed the initial tranche of a $150 million Bitcoin investment from Scilex Holding Company (Nasdaq: SCLX). The agreement includes the potential issuance of up to 278,914,094 shares of Datavault common stock at $0.5378 per share.
In this first tranche, Scilex received 15 million shares of Datavault common stock. The remaining investment will be issued as a pre-funded warrant in a second tranche, pending stockholder approval for share issuance exceeding 19.99% of Datavault's pre-financing outstanding shares.
Scilex Holding Company (Nasdaq: SCLX), a revenue-generating company focused on non-opioid pain management and disease treatments, has completed the initial tranche of its $150 million Bitcoin investment in Datavault AI Inc. (Nasdaq: DVLT).
As part of this transaction, Scilex received 15 million shares of Datavault common stock at an effective price of $0.5378 per share. The remaining shares, totaling up to 278,914,094 shares, will be issued in a second tranche as a pre-funded warrant, pending Datavault stockholder approval for issuances exceeding 19.99% of pre-financing shares.
FAQ
What is the current stock price of Scilex Holding Co (SCLX)?
What is the market cap of Scilex Holding Co (SCLX)?
